ddp4 inhibitor and glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Frontiers | Clinical Use of

For individuals on GLP-1 diabetes medications who are already struggling with reduced fluid intake, this increased carbohydrate consumption can create additional hydration demands that are difficult to meet through thirst cues alone, potentially leading to dehydration and nutrient deficiencies

While GLP-1s are effective for weight loss, they are not clinically appropriate for everyone

That's one drug with multiple uses

Physical Risks: Gastrointestinal Issues: Including nausea, vomiting, and abdominal pain

Compared with acute pain, chronic pain is known to be much more harmful to the human body (93)

The Bottom Line If you have PMOS and feel like your metabolism has gone rogue, this is exactly where a personalized plan matters